Synthesis of New 1-Substituted-3-(3-(2-Chlorophenyl)-4-Oxo-3,4-Dihydrobenzopyrimidin-2-Ylamino)Isothioureas as Anti-HIV and Antibacterial Agents
In this study, a new benzopyrimidine analog was designed and synthesized by substituting 3-nitrophenyl ring and thiosemicarbazide nucleus at N-3 and C-2 positions of quinazoline ring, respectively. The title compounds, 1-substituted-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)iso...
Saved in:
Published in | Pharmaceutical chemistry journal Vol. 55; no. 1; pp. 54 - 59 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.04.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In this study, a new benzopyrimidine analog was designed and synthesized by substituting 3-nitrophenyl ring and thiosemicarbazide nucleus at N-3 and C-2 positions of quinazoline ring, respectively. The title compounds, 1-substituted-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)isothioureas
7A – 7J
were obtained via reactions of 2-hydrazino-3-(2-chlorophenyl)quinazolin-4(3
H)
-one (
5
) with different alkyl/aryl isothiocyanates followed by methylation with dimethyl sulphate. All synthesized compounds were screened for their antitubercular, anti-HIV, and antibacterial activity against selected Gram-positive and Gram-negative bacteria using agar diffusion method. Amongst, compounds 2-methyl-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)-1-(3-chloropheny)isothiourea
(7I)
and 2-methyl-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)-1-(3-chlorophenyl)isothiourea
(7F)
showed the most potent activity against
P. vulgaris
and
S. aureus
with a MIC of 3 μg/mL
.
Compound
7I
exhibited antitubercular activity at a minimum MIC of 3.125 μg/mL and anti-HIV activity at EC
50
of 2.91 μg/mL against HIV1 and HIV2, thus offering probable lead for further development and optimization of new antitubercular and anti-HIV drugs. Results obtained in this study confirm that the synthesized and biologically evaluated benzopyrimidines possess promising antimicrobial, antitubercular, and anti-HIV properties and provide new scaffolds for antimicrobial activity. |
---|---|
AbstractList | In this study, a new benzopyrimidine analog was designed and synthesized by substituting 3-nitrophenyl ring and thiosemicarbazide nucleus at N-3 and C-2 positions of quinazoline ring, respectively. The title compounds, 1-substituted-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)isothioureas
7A – 7J
were obtained via reactions of 2-hydrazino-3-(2-chlorophenyl)quinazolin-4(3
H)
-one (
5
) with different alkyl/aryl isothiocyanates followed by methylation with dimethyl sulphate. All synthesized compounds were screened for their antitubercular, anti-HIV, and antibacterial activity against selected Gram-positive and Gram-negative bacteria using agar diffusion method. Amongst, compounds 2-methyl-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)-1-(3-chloropheny)isothiourea
(7I)
and 2-methyl-3-(3-(2-chlorophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-ylamino)-1-(3-chlorophenyl)isothiourea
(7F)
showed the most potent activity against
P. vulgaris
and
S. aureus
with a MIC of 3 μg/mL
.
Compound
7I
exhibited antitubercular activity at a minimum MIC of 3.125 μg/mL and anti-HIV activity at EC
50
of 2.91 μg/mL against HIV1 and HIV2, thus offering probable lead for further development and optimization of new antitubercular and anti-HIV drugs. Results obtained in this study confirm that the synthesized and biologically evaluated benzopyrimidines possess promising antimicrobial, antitubercular, and anti-HIV properties and provide new scaffolds for antimicrobial activity. |
Author | Chitra, K. Alagarsamy, V. Narendhar, B. |
Author_xml | – sequence: 1 givenname: B. surname: Narendhar fullname: Narendhar, B. organization: Medicinal Chemistry Research Laboratory, MNR College of Pharmacy – sequence: 2 givenname: K. surname: Chitra fullname: Chitra, K. organization: Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University) – sequence: 3 givenname: V. surname: Alagarsamy fullname: Alagarsamy, V. email: drvalagarsamy@gmail.com organization: Medicinal Chemistry Research Laboratory, MNR College of Pharmacy |
BookMark | eNp9kNtKAzEQhoMoWA8v4NVeWnA0p900l6WeCqIXHtCrJbub7aZsk5Kk6PoUPrLRei38wzAw__DPd4B2rbMaoROCzwnG4iIQgiUHTEkqJgiIHTQiuWAgMSO7aISxJEBy_LqPDkJYYpxsjI7Q1-NgY6eDCZlrs3v9nhF43FQhmriJugEGp0kUZl3vvFt32g79GDg8fDhgZxwuTTc03lXafrr14M3KNMYChbderYx143lwsTNu47UKWdLURgO385dM2eZ3qFQdtTeqz6YLbWM4Qnut6oM-_uuH6Pn66ml2C3cPN_PZ9A5qKkmEvOWVmChaqFbRXBEx0RWTXIuCs6blE9w2RHKuGymKRuKcF6KqqWJcy4LUomKHiG7v1t6F4HVbrlN65YeS4PKHabllWiam5S_TUiQT25pCWrYL7ctles2mnP-5vgG30Hva |
CitedBy_id | crossref_primary_10_31857_S0514749223010044 crossref_primary_10_2174_1573406418666220620124034 crossref_primary_10_1134_S1070428023010037 crossref_primary_10_1134_S1070428023070035 crossref_primary_10_31857_S0514749223070030 crossref_primary_10_1002_cbdv_202300702 |
Cites_doi | 10.1021/ar7000843 10.1016/j.ejmech.2007.07.001 10.1016/j.bmcl.2008.12.088 10.4067/S0717-97072016000200002 10.1134/S106816201603002X 10.3402/gha.v8.27048 10.1080/13543776.2018.1432596 10.1016/j.bmc.2007.05.063 10.1016/j.ejmech.2018.03.076 10.1021/jm060339h 10.1111/j.1747-0285.2009.00794.x 10.1016/0223-5234(87)90277-7 10.1016/S1473-3099(09)70043-X 10.1016/j.bmc.2008.08.050 10.1016/j.ejmech.2010.01.028 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC, part of Springer Nature 2021 |
Copyright_xml | – notice: Springer Science+Business Media, LLC, part of Springer Nature 2021 |
DBID | AAYXX CITATION |
DOI | 10.1007/s11094-021-02371-7 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1573-9031 |
EndPage | 59 |
ExternalDocumentID | 10_1007_s11094_021_02371_7 |
GroupedDBID | --- -53 -58 -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 123 1N0 1SB 2.D 28- 29O 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 4.4 406 408 409 40D 40E 41~ 53G 5QI 5VS 642 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDBF ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPTK ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACSNA ACTTH ACUDM ACVWB ACWMK ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFGCZ AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BGNMA CAG COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD ESBYG ESX FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS HF~ HG6 HMJXF HQYDN HRMNR HVGLF HZ~ IAO IHE IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C JBSCW JCJTX JZLTJ KDC KOV KOW LAK LLZTM M4Y MA- MK0 N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P9N PF0 PT4 PT5 QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3B SAP SCLPG SCM SDE SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW STPWE SZ9 SZN T13 T16 TEORI TSG TSK TSV TUC TUS U2A U9L UG4 UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 W4F WJK WK8 XU3 YLTOR Z7U Z7V Z7W Z87 Z8O Z8P Z8Q Z91 ZGI ZMTXR ZOVNA ~8M ~A9 ~EX ~KM AACDK AAEOY AAJBT AASML AAYXX ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF CITATION H13 |
ID | FETCH-LOGICAL-c291t-5f4b78a26afa25a178eb394e7643df480fd1944ed976d905467bc2a34e961c7b3 |
IEDL.DBID | U2A |
ISSN | 0091-150X |
IngestDate | Thu Sep 12 16:36:59 EDT 2024 Sat Dec 16 12:09:56 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | substituted thiosemicarbazide quinazolinone antibacterial activity, antitubercular activity, anti-HIV activity condensed pyrimidine |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c291t-5f4b78a26afa25a178eb394e7643df480fd1944ed976d905467bc2a34e961c7b3 |
PageCount | 6 |
ParticipantIDs | crossref_primary_10_1007_s11094_021_02371_7 springer_journals_10_1007_s11094_021_02371_7 |
PublicationCentury | 2000 |
PublicationDate | 2021-04-01 |
PublicationDateYYYYMMDD | 2021-04-01 |
PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York |
PublicationTitle | Pharmaceutical chemistry journal |
PublicationTitleAbbrev | Pharm Chem J |
PublicationYear | 2021 |
Publisher | Springer US |
Publisher_xml | – name: Springer US |
References | AlagarsamyVSolomonVRSheoreyRVChem. Biol. Drug. Des.2009734714791:CAS:528:DC%2BD1MXktVWhsrc%3D10.1111/j.1747-0285.2009.00794.x KaraliNGürsoyAKandemirliFBioorg. Med. Chem.200715588859041:CAS:528:DC%2BD2sXnslWjtr8%3D10.1016/j.bmc.2007.05.063 Turan-ZitouniGOzdemirAKaplancikliZAEur. J. Med. Chem.2008439819851:CAS:528:DC%2BD1cXlslKmu70%3D10.1016/j.ejmech.2007.07.001 MeunierBAcc. Chem. Res.20084169771:CAS:528:DC%2BD2sXotlOjtr8%3D10.1021/ar7000843 HameedAAl-RashidaMUroosMExpert Opin. Ther. Pat.2018282812971:CAS:528:DC%2BC1cXisVektbs%3D10.1080/13543776.2018.1432596 AlagarsamyVAnjanaGVSulthanaMTRuss. J Bioorg. Chem.2016423323391:CAS:528:DC%2BC28XovV2isrc%3D10.1134/S106816201603002X GüzelOKaraliNSalmanABioorg. Med. Chem.2008168976898710.1016/j.bmc.2008.08.050 FarghalyAMOmarAMMEKhalilMAEur. J. Med. Chem.1987223693711:CAS:528:DyaL1cXhtFagur0%3D10.1016/0223-5234(87)90277-7 WHO: Global Tuberculosis Report 2018, World Health Organization, Geneva, Switzerland (2018). F. R. Pavan, P. I. Da S Maia, S. R. Leite, et. al., Eur. J. Med. Chem.,45, 1898 – 1905 (2010). PandeyaSNSmithaSJyotiMActa. Pharm.20055527461:CAS:528:DC%2BD2MXksVagsrs%3D15907222 V. Alagarsamy, K. Chitra, G. Saravanan, et. al., Eur. J. Med. Chem., 151, 628 – 685 (2018). WHO: Tuberculosis, Available online: https://www.who.int / tb/en/ (accessed on 17 March 2019). SriramDYogeeswariPThirumuruganRJ. Med. Chem.200649344834501:CAS:528:DC%2BD28XkslKhtL0%3D10.1021/jm060339h B. Milczarska, H. Foks, J. Sokołowska, et al., Acta Pol. Pharm.,56, 121 – 126 (1999). E. Saripinar, Y. Güzel, S. Patat, et. al., Arzneimittelforschung, 46, 824 – 828 (1996). ReidMJShahNSLancet Infect. Dis.2009917318410.1016/S1473-3099(09)70043-X AlagarsamyVAppaniRSulthanaMTJ Chil. Chem. Soc.201661285628601:CAS:528:DC%2BC28Xhs1Oqur7F10.4067/S0717-97072016000200002 BalchaTTSkogmarSSturegårdEGlob. Health Action20158270482704910.3402/gha.v8.27048 SriramDYogeeswariPDhaklaPBioorg. Med. Chem. Lett.200919115211541:CAS:528:DC%2BD1MXit1WrtLc%3D10.1016/j.bmcl.2008.12.088 V Alagarsamy (2371_CR17) 2009; 73 D Sriram (2371_CR11) 2009; 19 SN Pandeya (2371_CR15) 2005; 55 N Karali (2371_CR9) 2007; 15 A Hameed (2371_CR6) 2018; 28 G Turan-Zitouni (2371_CR14) 2008; 43 O Güzel (2371_CR8) 2008; 16 D Sriram (2371_CR10) 2006; 49 TT Balcha (2371_CR2) 2015; 8 2371_CR1 2371_CR4 B Meunier (2371_CR16) 2008; 41 2371_CR5 V Alagarsamy (2371_CR19) 2016; 42 2371_CR7 AM Farghaly (2371_CR20) 1987; 22 MJ Reid (2371_CR3) 2009; 9 2371_CR12 2371_CR13 V Alagarsamy (2371_CR18) 2016; 61 |
References_xml | – volume: 41 start-page: 69 year: 2008 ident: 2371_CR16 publication-title: Acc. Chem. Res. doi: 10.1021/ar7000843 contributor: fullname: B Meunier – volume: 43 start-page: 981 year: 2008 ident: 2371_CR14 publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2007.07.001 contributor: fullname: G Turan-Zitouni – volume: 19 start-page: 1152 year: 2009 ident: 2371_CR11 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2008.12.088 contributor: fullname: D Sriram – ident: 2371_CR4 – volume: 55 start-page: 27 year: 2005 ident: 2371_CR15 publication-title: Acta. Pharm. contributor: fullname: SN Pandeya – volume: 61 start-page: 2856 year: 2016 ident: 2371_CR18 publication-title: J Chil. Chem. Soc. doi: 10.4067/S0717-97072016000200002 contributor: fullname: V Alagarsamy – volume: 42 start-page: 332 year: 2016 ident: 2371_CR19 publication-title: Russ. J Bioorg. Chem. doi: 10.1134/S106816201603002X contributor: fullname: V Alagarsamy – ident: 2371_CR1 – volume: 8 start-page: 27048 year: 2015 ident: 2371_CR2 publication-title: Glob. Health Action doi: 10.3402/gha.v8.27048 contributor: fullname: TT Balcha – volume: 28 start-page: 281 year: 2018 ident: 2371_CR6 publication-title: Expert Opin. Ther. Pat. doi: 10.1080/13543776.2018.1432596 contributor: fullname: A Hameed – ident: 2371_CR12 – ident: 2371_CR13 – volume: 15 start-page: 5888 year: 2007 ident: 2371_CR9 publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2007.05.063 contributor: fullname: N Karali – ident: 2371_CR5 doi: 10.1016/j.ejmech.2018.03.076 – volume: 49 start-page: 3448 year: 2006 ident: 2371_CR10 publication-title: J. Med. Chem. doi: 10.1021/jm060339h contributor: fullname: D Sriram – volume: 73 start-page: 471 year: 2009 ident: 2371_CR17 publication-title: Chem. Biol. Drug. Des. doi: 10.1111/j.1747-0285.2009.00794.x contributor: fullname: V Alagarsamy – volume: 22 start-page: 369 year: 1987 ident: 2371_CR20 publication-title: Eur. J. Med. Chem. doi: 10.1016/0223-5234(87)90277-7 contributor: fullname: AM Farghaly – volume: 9 start-page: 173 year: 2009 ident: 2371_CR3 publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(09)70043-X contributor: fullname: MJ Reid – volume: 16 start-page: 8976 year: 2008 ident: 2371_CR8 publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2008.08.050 contributor: fullname: O Güzel – ident: 2371_CR7 doi: 10.1016/j.ejmech.2010.01.028 |
SSID | ssj0010032 |
Score | 2.2781537 |
Snippet | In this study, a new benzopyrimidine analog was designed and synthesized by substituting 3-nitrophenyl ring and thiosemicarbazide nucleus at N-3 and C-2... |
SourceID | crossref springer |
SourceType | Aggregation Database Publisher |
StartPage | 54 |
SubjectTerms | Medicine Organic Chemistry Pharmacology/Toxicology Pharmacy |
Title | Synthesis of New 1-Substituted-3-(3-(2-Chlorophenyl)-4-Oxo-3,4-Dihydrobenzopyrimidin-2-Ylamino)Isothioureas as Anti-HIV and Antibacterial Agents |
URI | https://link.springer.com/article/10.1007/s11094-021-02371-7 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Na9wwEBVtAm0vIdm25KtBhxIaugMrWbbs47JNumlpG2i2bE5GXknEUOQQbyDOr8hPzkj2xgRKIaCLQQjMm9G8YWaeCPmoLfOtFgIw1I1AmChDl4olmEzoRBimmQ5qnz-T6Ux8m8fzfo47NLuvKpLhou5n3djIq9hyzH55JBnIl2Q99nJoaMQzPn4sHaCZthLhGQNkO_NuUubfZzyNRk9LoSHCnGySjY4a0nGL5RZ5YdyAvJ6sXmQbkFc_ukL4gByetZLTzZCe9xNU9ZAe0rNejLp5S-5_Nw45Xl3WtLIUrzTKwF8WbYeAhgg-4eIwucTE3WsMuObvEQj4dVtBNBTwpbxstB8ZcnfVVePfAMNgBxwu0JJKVx2d1gh1WYXedopr7JYlTE__UOV0-ChaOWj_Y36Kq35HZifH55MpdK8wwIJnbAmxFYVMFU-UVTxWTKaYf2fCSOQy2op0ZDXLhDAa0dYZMsBEFguuImGyhC1kEb0na65yZptQzFWNHUllF0hiLHq-zy_jJDWpV4lRaod8XqGRX7ViG3kvq-yxyxG7PGCXyx0yXAGWd45X_2f77vO275E3PBiKb9LZJ2vL6xvzAfnHsjgg6-OvF9-PD4LdPQBhstDn |
link.rule.ids | 315,783,787,27936,27937,41093,41535,42162,42604,52123,52246 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3batwwEB3aDTR96WXb0PSqhxIauhNWsmzZj8s26W5zaaC7ZfNkbEsmpsEOsQN1vqKf3JEvXVJKIeAXgzAyczRzhpk5AnivU25bLSRSqBujNE5AR8pVaAKpPWm45rpR-zzxZkv5ZeWuuqGwsu9270uSjadeD7vxsZWxFZT-CkdxVPdhQwruiQFsTD6fHe7_qR4QUluV8IAjEZ5VNyzz76_cDki3q6FNkDl4DMt-e21vyY-96yreS27-Um686_6fwKOOdbJJC5OncM_kQ9ic9pe9DeHBcVdjH8LOaatmXY_YYj2cVY7YDjtd61zXz-DXtzon-lhmJStSRt6ScbR-qG0-0OjgB3oETs8viisrX5DXF7so8evPAp2RxE_Zea3tNFJ-U1zW9noxiqMo8IxAmuXF7rwkFGVF0zbP6JnkVYaz-XcW5bp5iVulaftjdkCsfA7Lg_3FdIbdBQ-YiIBX6KYyVn4kvCiNhBtx5VNqH0ijiCbpVPrjVPNASqMJSDogcumpOBGRI03g8UTFzhYM8iI3L4BRGmzSsYrShPhRSk7Fpq6u5xvfCtBE0TZ87K0cXrY6HuFasdlaJiTLhI1lQrUNo96GYXemy_8sf3m35e9gc7Y4PgqP5ieHr-ChaCBhe4Few6C6ujZviOZU8dsO1b8BUALvnA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ba9swFBZbCt1edslW1l31MMrKctrIViz7MaTNknXrAmtH-mRkS6JmRQ61C3N_xX7yjnxZ1jEGY6AXgxAW55POOZzzfSLktTLMtVpwQFc3BK79CI_USICOuAq4ZoqpWu3zOJid8vfL0fIXFn_d7d6VJBtOg1NpsuX-Spn9NfGNDZ2krYepsOcLBuI22eBOGalHNsbvzo4Of1YSELWNYnjEAIOfZUuc-fMqN53Tzcpo7XCm94nsfrXpM_m6d1Ume-n1byqO_7OXB-ReG43ScQOfh-SWtn1yZ9I9Atcnmx_b2nuf7CwaletqQE_WpK1iQHfoYq1_XT0i3z9XFsPKIitobijeopSBu5-apgQFPrzB4cHk_CK_dLIGtrrYBQ6fvuXgDzgcZOeVciwle52vKvfsGPpX8OAMwZvZfHdeILqyvG6npzjGtsxgNv9CpVX1R9IoULuNOeJY8ZicTg9PJjNoH36A1ItYCSPDExFKL5BGeiPJRIgpf8S1wPBJGR4OjWIR51ohwFSEQWcgktSTPtdRwFKR-FukZ3OrnxCK6bE2QyFNinGTwcvGpbSjINShE6aRcpu87Swerxp9j3it5OwsE6Nl4toysdgmg86ecXvWi79Mf_pv01-RzcXBNP4wPz56Ru56NSJci9Bz0isvr_QLjH7K5GUL8B9fEviA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+of+New+1-Substituted-3-%283-%282-Chlorophenyl%29-4-Oxo-3%2C4-Dihydrobenzopyrimidin-2-Ylamino%29Isothioureas+as+Anti-HIV+and+Antibacterial+Agents&rft.jtitle=Pharmaceutical+chemistry+journal&rft.au=Narendhar%2C+B.&rft.au=Chitra%2C+K.&rft.au=Alagarsamy%2C+V.&rft.date=2021-04-01&rft.issn=0091-150X&rft.eissn=1573-9031&rft.volume=55&rft.issue=1&rft.spage=54&rft.epage=59&rft_id=info:doi/10.1007%2Fs11094-021-02371-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11094_021_02371_7 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-150X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-150X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-150X&client=summon |